Plain-English translation of NCT06476470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that will follow patients with fibrotic interstitial lung disease (a condition where lung tissue becomes scarred and stiff) across multiple hospitals in Taiwan. Researchers will collect medical information, imaging scans, blood samples, and exercise test results over time to understand how the disease progresses, what factors predict outcomes, and how well current treatments work for different types of lung fibrosis.
Fibrotic lung disease can progress differently depending on its cause, and doctors need real-world information to better predict which patients are at higher risk and which treatments work best. This study will help answer important questions about survival, disease worsening, and the role of biomarkers and imaging in predicting outcomes.
You likely qualify if…
You likely don't qualify if…
You would visit participating hospitals regularly over an extended period to have medical tests and provide information. These visits would include yearly high-resolution CT scans of your lungs, yearly exercise tests to measure how well your lungs work, blood draws for research, and heart ultrasounds and breathing tests every six months. Your medical history, symptoms, and treatment responses would also be documented to help researchers track how your condition changes over time.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Taiwan